Phase 2 Lupus Trial, Recruiting NCT06058078 Sponsor: Jiangsu Renocell Biotech Company Condition: Lupus
Back to Lupus

Phase 2 Lupus Trial, Recruiting

NCT06058078
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing to sign a consent form agreeing to take part voluntarily.
  • You are between 18 and 65 years old (male or female).
  • You have been diagnosed with lupus (SLE) meeting at least 4 out of 11 specific medical criteria, and your disease is currently considered moderately to severely active based on a standard scoring system.
  • You have previously tried a combination of treatments for lupus (such as steroids with other medicines), but either could not tolerate them or they did not work well enough.
  • You have been diagnosed with a specific type of kidney inflammation caused by lupus (called lupus nephritis, class III or IV, with or without class V), confirmed by a kidney biopsy.
  • Your urine tests show a significant amount of protein leaking into your urine, above a certain level (confirm with trial site for exact values).
  • You agree not to try to become pregnant or donate sperm or eggs during the trial and for at least 1 year afterward, and you agree to use effective contraception during this time.

Who may not be able to join:

  • You have serious liver problems, shown by certain blood test results being more than twice the normal range.
  • Your kidneys are functioning very poorly, based on specific blood or lab measurements falling below or above set levels.
  • Your kidney biopsy shows that 50% or more of the filtering units in your kidneys are permanently scarred.
  • Your blood counts are very low in any of the following areas: white blood cells, red blood cells (causing severe anaemia), platelets, or a specific type of infection-fighting cell called neutrophils.
  • You have a serious, uncontrolled condition affecting your heart, lungs, nervous system, liver, hormones (such as uncontrolled diabetes), or digestive system — including very high blood pressure, significant heart failure, a heart attack in the last 6 months, a stroke in the last 6 months, severe high blood pressure in the lungs, or serious heart rhythm problems.
  • You have a history of a condition where your immune system does not produce enough of a protein called IgA.
  • You have another autoimmune disease in addition to lupus (such as rheumatoid arthritis or systemic sclerosis), although having a secondary condition called Sjögren's syndrome is allowed.
  • You have received a live or weakened live vaccine in the past 12 weeks, or expect to need one during the trial.
  • You have had a specific blood-cleaning treatment (plasmapheresis or immunoadsorption) in the past 24 weeks, or received a treatment called IVIG in the past 4 weeks.
  • You have taken part in another clinical drug trial in the past 12 weeks.
  • You have tested positive for HIV, active syphilis, active hepatitis C, or hepatitis B (at certain levels), or you have had a serious or recurring infection recently.
  • You have been diagnosed with any cancer in the past 5 years, including blood cancers or tumours in organs (except certain fully treated skin cancers).
  • You have had major surgery in the past 12 weeks, or are expected to need major surgery during the trial, which the trial doctor considers too risky.
  • You are allergic to the treatment used in this trial (which involves stem cells) or to any of its ingredients, including human albumin; or you cannot take steroid medicines; or you do not have a suitable vein for an intravenous drip.
  • You are currently pregnant or breastfeeding.
  • In the past 12 months, you have smoked 5 or more cigarettes a day on average, regularly drunk more than 14 units of alcohol per week, or have used illegal drugs or tested positive on a drug screening test.
  • The trial doctor has decided for any other reason that the trial may not be suitable for you (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Sun Lingyun, the Affiliated Drum Tower Hospital, Medical School, Nanjing University

Phone: 15852926678

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Jiangsu Renocell Biotech Company
Registry
ClinicalTrials.gov
Start date
17 August 2023
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Frequency of Adverse Events; Proportion of patients achieving a primary renal efficacy response (PERR); Proportion of patients achieving a complete response (CR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov